A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral ...

Data highlight both SER-603’s rational design that targets microbial functions linked to mucosal healing and gastrointestinal inflammation in ...

Eli Lilly and Co. LLY shares are trading higher on Tuesday as the company is reporting new data on its treatment for ...

Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, affects millions and can be life-altering ...

Water is often dubbed the elixir of life, and for a good reason. It is a crucial component of our bodies, making up about 60 percent of our total body weight. Every cell, tissue and organ in our body ...

High stress and late-night eating combined are linked to significantly increased risk for abnormal bowel habits and reduced ...

Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster ...

Treatment for short bowel syndrome varies by stage and may include intravenous (IV) nutrition, feeding tubes, dietary changes ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...